132 related articles for article (PubMed ID: 11543647)
1. Amine metabolism: a novel path to coronary artery vasospasm.
Conklin DJ; Boyce CL; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2001 Sep; 175(2):149-59. PubMed ID: 11543647
[TBL] [Abstract][Full Text] [Related]
2. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
[TBL] [Abstract][Full Text] [Related]
3. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
[TBL] [Abstract][Full Text] [Related]
4. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
Pino R; Lyles GA
Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
[TBL] [Abstract][Full Text] [Related]
5. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Conklin DJ; Trent MB; Boor PJ
Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
[TBL] [Abstract][Full Text] [Related]
6. Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats.
Conklin DJ; Boor PJ
Toxicol Appl Pharmacol; 1998 Feb; 148(2):245-51. PubMed ID: 9473532
[TBL] [Abstract][Full Text] [Related]
7. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Conklin DJ; Langford SD; Boor PJ
Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
[TBL] [Abstract][Full Text] [Related]
8. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
9. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Ramos K; Grossman SL; Cox LR
Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase 8-8 is localized in smooth muscle cells of rat aorta and is induced in an experimental model of atherosclerosis.
Misra P; Srivastava SK; Singhal SS; Awasthi S; Awasthi YC; Boor PJ
Toxicol Appl Pharmacol; 1995 Jul; 133(1):27-33. PubMed ID: 7597707
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
12. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
Awasthi S; Boor PJ
Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
[TBL] [Abstract][Full Text] [Related]
13. Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse.
Mercier N; Osborne-Pellegrin M; El Hadri K; Kakou A; Labat C; Loufrani L; Henrion D; Challande P; Jalkanen S; Fève B; Lacolley P
Cardiovasc Res; 2006 Nov; 72(2):349-57. PubMed ID: 16989792
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of semicarbazide-sensitive amine oxidase from porcine aorta.
Tipnis UR; Tao M; Boor PJ
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):575-84. PubMed ID: 1483111
[TBL] [Abstract][Full Text] [Related]
15. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
16. Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
Kumar D; Trent MB; Boor PJ
Toxicology; 1998 Feb; 125(2-3):107-15. PubMed ID: 9570326
[TBL] [Abstract][Full Text] [Related]
17. Vascular amine oxidase activities during synergistic vasculotoxicity.
Trent MB; Boor PJ
Toxicology; 1994 Mar; 89(1):67-77. PubMed ID: 7909964
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
19. Effect of benzylamine and its metabolites on the responses of the isolated perfused mesenteric arterial bed of the rat.
Elliott J; Callingham BA
J Auton Pharmacol; 1991 Oct; 11(5):323-35. PubMed ID: 1748692
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
